The FDA has approved a monthly dosing schedule for subcutaneous amivantamab in NSCLC following the first 4 weeks of treatment ...
Emese Zsiros, MD, PhD, FACOG, discusses managing paclitaxel toxicity and the role of pembrolizumab maintenance in treating ...
Practical examples of advanced practice provider–led initiatives that improve safety, symptom management, and patient ...
The FDA updated its safety labeling for capecitabine and 5-FU to reflect that patients with certain genetic variants risk ...
Rinatabart sesutecan (Rina-S) demonstrated a 100% disease control rate at the 100-mg/m 2 dose for patients with heavily ...
Jakel shared the story of a young mother who had been deemed difficult and “in denial” by other staff due to her rejecting ...
The advantage of MCED testing is its potential to identify cancers at earlier, more treatable stages; detecting cancer even ...
RMAT status for KB707 enables expedited development with enhanced FDA engagement, supported by early KYANITE-1 activity and durability in heavily pretreated advanced/metastatic NSCLC. LungTIME-C01 ...
The FDA has approved Optune Pax, a wearable medical device that delivers Tumor Treating Fields (TTFields), for the treatment of adult patients with locally advanced pancreatic cancer (LA-PAC) ...
David C. Leopold, MD, explains how evidence-based integrative therapies like acupuncture and nutrition improve oncology patient outcomes and compliance. Integrative therapies such as acupuncture, ...
In a clip from the latest Onc Nurse on Call episode, social worker Kelly Grosklags explains that emotions strengthen the connection between patient and clinician in oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results